Ovarian carcinoma has been the subject of sustained clinical investigation across multiple research sites.

30 total trials for this combination

Showing top 10 of 30 trials

Trials

NCT ID	Title	Status	Phase
NCT04981119	Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing	RECRUITING	—
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ACTIVE_NOT_RECRUITING	—
NCT06172478	A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors	RECRUITING	PHASE2
NCT04969835	A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours	RECRUITING	PHASE1
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ACTIVE_NOT_RECRUITING	—
NCT07038369	A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations	ACTIVE_NOT_RECRUITING	PHASE1
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ACTIVE_NOT_RECRUITING	—
NCT05194735	Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors	TERMINATED	PHASE1/PHASE2
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ACTIVE_NOT_RECRUITING	—
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ACTIVE_NOT_RECRUITING	—

Related Pages

All Ovarian carcinoma trials All trials in Houston, United States